Complications of immunotherapy in advanced hepatocellular carcinoma
Immune checkpoint inhibitors (ICIs) are highly effective in cancer treatment. However, the risks associated with the treatment must be carefully balanced against the therapeutic benefits. Immune-related adverse events (irAEs) are generally unpredictable and may persist over an extended period. In th...
| Auteurs principaux: | , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
Korean Liver Cancer Association
2024-03-01
|
| Collection: | Journal of Liver Cancer |
| Sujets: | |
| Accès en ligne: | http://www.e-jlc.org/upload/pdf/jlc-2023-11-21.pdf |